Adenocard

This fundamental building block of life will stop your heart – just long enough to be useful - Christina Shenvi MD PhD

Adenocard

HWN Suggests

All About Adenosine

 

Adenosine is one of components of RNA, but given intravenously, it works to terminate SVTs by binding to the AV node’s A1 receptors. This inhibits adenylyl cyclase, ultimately increasing potassium efflux from the cell, causing hyperpolarization, and thereby “blocking” the AV node. This prevents atrial impulses from reaching the ventricles through the AV node, and also blocks re-entrant tachycardias that rely on conduction through the AV node.

read full article

Featured

 What is the concern with giving adenosine to a patient with WPW that is in SVT?

The concern with using adenosine in patients with WPW is that if the AV node is blocked than impulses from the atria will be able to reach the ventricles at a very rapid rate, since they are not slowed down through the accessory pathway as they are at the AV node. Rapid ventricular rates (ventricular tachycardia or ventricular fibrillation) lead to incomplete ventricular filling, poor output, and cardiac arrest. This is why AV nodal blockers are contraindicated in patients with WPW and atrial fibrillation, which can see atrial rates up to 600bpm.

Articles of Interest

Single Syringe Adenosine for SVT?

From a pragmatic standpoint, single syringe adenosine makes sense, and although we now have two small studies that show single syringe adenosine to be non-inferior to two syringe adenosine, we have to be cautious about making robust conclusions based on this level of evidence.

Trick of the Trade: Combine Adenosine with the Flush

While most drugs are metabolized in the liver, adenosine doesn’t even make it that far, being metabolized in the erythrocytes and vascular endothelial cells. With this extremely short half-life (10 seconds), it is important to help it reach the heart before it’s metabolized and excreted without being effective.

Would you choose adenosine?

Go low and go slow. Although the diltiazem dose used in the Lim study was 2.5 mg/min to a maximum of 50 mg, 75% of patients had converted by 18mg. I tend to give 15 mg of diltiazem over 10 minutes. It almost always works, but when it doesn’t I just repeat the dose.

Resources

Adenocard

If the first dose does not result in elimination of the supraventricular tachycardia within 1-2 minutes, 12 mg should be given as a rapid intravenous bolus. This 12 mg dose may be repeated a second time if required.

stay connected